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Prevalence of Gastroesophageal Reflux in Cats During Anesthesia
and Effect of Omeprazole on Gastric pH
R.S. Garcia, P.C. Belafsky, A. Della Maggiore, J.M. Osborn, B.H. Pypendop, T. Pierce, V.J. Walker,
A. Fulton, and S.L. Marks
Background: Gastroesophageal reflux (GER) is poorly characterized in anesthetized cats, but can cause aspiration pneu-
monia, esophagitis, and esophageal stricture formation.
Objective: To determine whether pre-anesthetic orally administered omeprazole increases gastric and esophageal pH and
increases serum gastrin concentrations in anesthetized cats, and to determine the prevalence of GER using combined multi-
channel impedance and pH monitoring.
Animals: Twenty-seven healthy cats undergoing elective dental procedures.
Methods: Prospective, double-masked, placebo-controlled, randomized clinical trial. Cats were randomized to receive 2
PO doses of omeprazole (1.45–2.20 mg/kg) or an empty gelatin capsule placebo 18–24 hours and 4 hours before anesthetic
induction. Blood for measurement of serum gastrin concentration was collected during anesthetic induction. An esophageal
pH/impedance catheter was utilized to continuously measure esophageal pH and detect GER throughout anesthesia.
Results: Mean gastric pH in the cats that received omeprazole was 7.2  0.4 (range, 6.6–7.8) and was significantly higher
than the pH in cats that received the placebo 2.8  1.0 (range, 1.3–4.1; P < .001). Omeprazole administration was not associ-
ated with a significant increase in serum gastrin concentration (P = .616). Nine of 27 cats (33.3%) had ≥1 episode of GER
during anesthesia.
Conclusions and Clinical Relevance: Pre-anesthetic administration of 2 PO doses of omeprazole at a dosage of
1.45–2.20 mg/kg in cats was associated with a significant increase in gastric and esophageal pH within 24 hours, but was not
associated with a significant increase in serum gastrin concentration. Prevalence of reflux events in cats during anesthesia was
similar to that of dogs during anesthesia.
Key words: Esophagitis; Feline; Gastric pH; Impedance; Reflux.
Gastroesophageal reflux (GER) and its associatedsequelae are well-documented causes of morbidity
and potential mortality in several species, including peo-
ple, dogs, and cats.1–6 The lower esophageal sphincter
(LES) is the main physiologic barrier to GER by main-
tenance of LES tone.1,7,8 Maintenance of tone is com-
plex and involves neurologic (vagal, nonadrenergic
noncholinergic) and mechanical (diaphragmatic crural
pressure) inputs.7,8 Anesthesia-related GER was a sus-
pected cause of esophageal stricture in 64–71% of cats
after anesthesia,3,5,6 but only 2 studies have assessed the
incidence of GER in anesthetized cats.9,10 One study
used pH-metry to determine the incidence of GER in
anesthetized adult cats and documented an incidence
ranging from 12 to 16%, depending on the type of
anesthesia.9 A second study in kittens using a single
anesthetic protocol documented GER in 23% of the
kittens.10 Relaxation of the LES associated with the
administration of injectable and inhaled anesthetic
agents represents a primary mechanism for the
increased incidence of reflux.11,12
The diagnosis of GER in cats can be challenging
given the intermittent nature of the problem, lack of
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overt clinical signs, and the need for advanced diagnos-
tic equipment including esophageal pH catheters or pH
capsules, endoscopes, and videofluoroscopic units that
are not readily available to many veterinarians. Vide-
ofluoroscopy also is challenging to complete in nonse-
dated cats given the temperament of the animals during
restraint and the reluctance of cats to readily swallow
barium-soaked food.13 Esophageal pH monitoring was
considered the gold standard for documenting GER in
people and animals, but mounting evidence has docu-
mented that esophageal pH probes underestimate the
frequency of reflux events (RE) because of their insensi-
tivity to nonacid reflux and subtle changes in pH that
can be associated with many reflux events.14–16 Com-
bined multichannel intraluminal impedance (MII)/pH-
metry uses impedance technology to determine the type
(liquid, gas) and incidence of reflux independent of its
acidity.14,16 Combined MII/pH-metry also allows for
detection of weakly acidic reflux (4.0 < pH < 7.0) and
weakly alkaline (pH ≥ 7.0) reflux events that have been
associated with esophagitis and respiratory symptoms in
people.14,17,18
Previous studies evaluating GER in anesthetized cats
exclusively have evaluated the incidence of reflux under
anesthesia using esophageal pH probes.9,10 Omeprazole
has been evaluated in humans and dogs to decrease
GER under anesthesia, but most studies have docu-
mented no effect of proton pump inhibitors (PPIs) on
frequency of RE. Prolonged exposure of the esophageal
mucosa to refluxed acid is an important cause of
esophagitis and potential stricture formation, particu-
larly when pH is <4.0 because the proteolytic pH range
for the conversion of pepsinogen to pepsin is between
1.5 and 3.5.19 Efforts to neutralize gastric acid by PO
administration of PPIs within 24 hours of anesthesia
induction and determination of the effects of 2 PO
doses of a PPI on serum gastrin concentrations have
not been determined in cats to date.20–25 Long-term PPI
therapy induces moderate hypergastrinemia and ente-
rochromaffin-like (ECL)-cell hyperplasia in most
patients, and hypergastrinemia has been used as a sur-
rogate marker of gastric acid suppression efficacy.26
Gastrin concentrations therefore may be a comparably
accurate measure of pharmacodynamic antisecretory
effects vs. measurements of gastric acid secretion.26
We hypothesized that pre-anesthetic administration
of omeprazole in cats undergoing elective periodontal
procedures would increase gastric and esophageal pH as
well as serum gastrin concentrations. In addition, we
hypothesized that the prevalence of GER in cats during
anesthesia was significantly lower than that of dogs
given the higher prevalence of clinically apparent
esophagitis and postanesthesia stricture formation in
dogs.
Materials and Methods
Animals
Client-owned cats admitted to the William R. Pritchard Veteri-
nary Medical Teaching Hospital (VMTH) at the University of
California, Davis, for elective dental procedures were recruited for
inclusion into this prospective, randomized, masked, placebo-con-
trolled study. All cats <6 years underwent a comprehensive physi-
cal examination, followed by a minimum database consisting of
measurement of hematocrit and plasma protein concentration,
semiquantitative assessment of blood urea nitrogen by dipstick,a
and urine specific gravity (USG) with a refractometer.b In addi-
tion, a CBC, biochemistry panel, urinalysis, and serum concentra-
tion of total T4 were performed on all cats ≥6 years old. Cats with
a history of GER, regurgitation, vomiting, esophagitis, and cough-
ing or cats that had received a gastric acid suppressant drug or
prokinetic medication within 2 weeks of anesthesia were excluded.
Hyperthyroid cats or cats with renal disease (IRIS stage I or
higher) also were excluded from the study. All laboratory testing
must have been completed within 1 month of the procedure date.
A sample size of 10 cats in each group, assuming a standard devia-
tion (SD) of 1.0, a 2-sided test, and a probability of type 1 error
equal to 0.05 had a power of 0.92 to detect a mean difference in
pH of 1.5. We chose to enroll 13 cats in each group to account for
attrition and achieved the desired level of power. The study proto-
col was evaluated and approved by the University of California,
Davis, School of Veterinary Medicine Animal Care and Use Com-
mittee (IACUC), and owners of all cats signed an informed con-
sent form before enrollment of the pet in the study.
Treatment Groups
Each cat was randomized by an Excel software programc ran-
dom number generator into 1 of 2 treatment groups to receive
either 2 PO doses of omeprazole sodiumd (1.45–2.20 mg/kg) or a
placebo of an empty gel cap (size # 4) followed by 10 mL of water
administered PO by syringe. Omeprazole capsules (20 mg) contain-
ing enteric-coated omeprazole granules were opened and the con-
tents evenly divided by weight to formulate 10 mg capsules that
again were placed into empty gel caps (size # 4). All treatments
were administered by 1 of the investigators who was not involved
in the interpretation of the pH/impedance results. A first dose of
omeprazole or placebo was given PO 18–24 hours before induc-
tion, and a second dose was administered PO 4 hours before
induction.
Gastrin Assay
Blood was collected into a serum tube (without serum separator
gel) from the cephalic or medial saphenous vein at the time of IV
catheter placement within 15 minutes of anesthetic induction. Serum
samples were stored at 80°C until being batch-mailed for determi-
nation of serum gastrin concentrations at Michigan State University
Diagnostic Center for Population and Animal Health. Serum gastrin
concentration was determined with a commercially available
radioimmunoassay kit according to the manufacturer’s protocol.e
The laboratory reported the following percentage cross-reactivity
with related compounds: gastrin 17-I (100%), gastrin 17-II (77%),
gastrin 34-I (42%), gastrin 5–17 (54%), cholecystokinin-PZ
(<0.1%), and cholecystokinin-8 (10.9%). The laboratory-reported
limit of detection was 3 ng/L. For intra-assay repeatability (10 repli-
cates), the coefficient of variation (COV) for a feline sample with a
gastrin concentration of 45 ng/L was 8.6%. For interassay repeata-
bility (10 replicates), the COV for a feline sample with a gastrin con-
centration of 54 ng/L was 9.2%.
Anesthetic Protocol
All cats were fasted for at least 12 hours before induction. The
anesthetic protocol was identical in each cat, consisting of premedi-
cation with oxymorphonef (0.05 mg/kg SC) and atropineg
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(0.02 mg/kg SC), followed by induction of anesthesia with
propofolh (4 mg/kg IV) and midazolami (0.2 mg/kg IV), titrated to
effect to produce a lack of palpebral reflex, ventromedial rotation
of the eyes, and jaw muscle relaxation. Anesthesia was maintained
in all cats with isofluranej (1–3%), titrated to maintain appropriate
procedural anesthetic depth. All cats were endotracheally intubated
and maintained in dorsal recumbency, and lactated Ringer’s
solutionk (10 mL/kg/h IV) was administered throughout anesthesia.
Esophageal temperature probes and stethoscopes were avoided
during anesthetic monitoring to minimize artifact during recording.
The anesthetist responsible for administering and monitoring anes-
thesia was masked to the treatment group assignment.
Measurement of Reflux
Immediately after induction of anesthesia, a 6.4-French (2.13-
mm) esophageal multi-use pH/impedance catheterl was attached to
an electrical external reference pad that was placed in the axillary
region of the cat. All of the pH/impedance catheters had 7 impe-
dance sensors, each in the form of a 4-mm cylindrical ring and
spaced 2 cm apart, as well as 1 pH sensor located approximately
2 cm from the tip of the catheter (Fig 1). The segment between each
pair of sensors, known as the impedance sensor spacing, corre-
sponds to 1 recording impedance channel, thus resulting in 6 corre-
sponding impedance channels along the length of the catheter.
The pH electrode of the MII-pH catheter was calibrated within
10 minutes of use in buffer solutions of pH 4.0 and 7.0 according
to the manufacturer’s instructions. The esophageal catheter was
coated with a water-based lubricantm and introduced into the left
or right naris and passed through the ventral nasal meatus into
the oropharynx where it was reflected rostrally with the aid of a
spay hook. Any residual lubricant was removed from the catheter
with a saline-moistened gauze, and the catheter then was guided
aborad into the esophagus by use of a loop snaren passed through
the biopsy channel of a video endoscope.o Catheter placement was
performed in all cats by 1 of 3 investigators (SLM, RSG, or
ADM) skilled in endoscope handling to ensure consistency in the
positioning of the catheter. The catheter was advanced into the
greater curvature region of the stomach in 32 cats to record gastric
pH for 2 minutes before the catheter was retracted into the distal
esophagus so that the pH sensor on the catheter was positioned
6 cm proximal to the gastroesophageal junction (GEJ) in all cats
with all of the catheter’s impedance rings and channels located
within the esophagus. Deionized water was used to rinse any resid-
ual gastric acid from the pH catheter, and air introduced into the
stomach and esophagus during catheter placement was carefully
suctioned. The catheter then was secured in place using butterfly
tape wrapped around the catheter and secured to the skin with
skin staplesp lateral to the naris and ventrolateral to the ipsilateral
zygomatic arch. The catheter was attached to a recording deviceq
from which data were uploaded to a computer by proprietary soft-
ware from the manufacturer.r The reasons for placing the catheter
transnasally (in contrast to transorally) were 2-fold: (1) to mini-
mize interference (movement and displacement) of the catheter
during the dental procedure, and (2) to avoid interference with the
dentist’s procedure and field of vision in the oral cavity. The
oropharynx was suctioned throughout the procedure to minimize
fluid entering the hypopharynx and esophagus and contaminating
the distally located pH sensor or impedance channels. Esophageal
pH and impedance were recorded throughout the dentistry proce-
dure until the catheter was removed immediately before extubation
of the cat. Data analysis was performed by proprietary software
from the manufacturers by 1 of the investigators (JO) who was
masked to the treatment group assignment.
Defining Reflux by Impedance
A reflux episode was defined as a 50% decrement in ohms seen
in 2 consecutive impedance channels in the distal esophagus for
>2 seconds from the pre-episodic esophageal baseline recording.
Impedance (Z) technology relies upon the principle of resistance to
the passage of flow of an electrical current and is inversely related
to conductivity. Impedance is influenced by the physical character-
istics of intraluminal substrates, and gastric refluxate has high elec-
trical conductivity, or low impedance, whereas intraluminal air has
a low conductivity, or high impedance. Interpretation of the wave-
form generated by the computer can be used to determine whether
the refluxate originated orally or aborally. In addition, the demar-
cated concentric impedance rings and impedance channels located
along the length of the catheter allow the investigator to determine
the distance the refluxate travels up the esophagus by assessing the
length of the waveform generated (Fig 2).
The pH of the refluxate was classified as strongly acidic
(pH < 4.0), weakly acidic (4.0 < pH < 7.0), or weakly alkaline
(pH ≥ 7.0). The mean acid clearance time was defined as the dura-
tion of each acid RE, beginning at the moment the pH decreased
to <4.0 and ending when the pH increased to ≥4.1. All cats were
monitored during the dentistry procedure for regurgitation or
reflux events by the anesthesiologist, and all events were recorded
in the anesthesia record of the animal.
Statistical Analysis
All data were coded and recorded into SPSS 22.0 for the Mac-
intosh computer.t Differences between group means were assessed
by the independent-samples t-test. All results were confirmed with
the nonparametric Mann-Whitney U-test. Statistical significance
was ascertained at a probability of type I error (a) of 0.05. A
A
B
Fig 1. Photograph of the 6.4-French (2.1-mm) esophageal multi-
use pH/impedance catheter showing impedance channels (arrow
heads), each 2 cm in length in between the impedance sensors,
each in the form of a 4-mm cylindrical ring, and one pH sensor
(arrow heads and arrow). The catheter is attached to the recording
device (ZepHr) from which data are uploaded onto a computer
using proprietary software.
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Bonferroni correction was utilized to adjust for multiple compar-
isons (1 primary and 3 secondary endpoints).
Results
Animals
Thirty-six cats were evaluated for enrollment in the
study, and 9 cats ultimately were excluded: 4 cats were
excluded because of small patient size (<4.0 kg) preclud-
ing transnasal passage of the esophageal catheter. Three
additional cats were excluded because of failure of pH/
impedance catheter calibration or failure of pH/impe-
dance data to be recorded. Two cats were excluded post-
procedure because of histories of chronic vomiting (1)
and chronic kidney disease (1) that were not apparent at
the time of enrollment. Of the 27 cats that completed the
study, 14 were assigned to the placebo group and 13 were
assigned to the omeprazole group. Drying of the pH sen-
sor on the catheter precluded accurate determination of
gastric and esophageal pH in 4 of the 27 cats, but this did
not affect impedance function, which allowed determina-
tion of RE in all cats. Seventeen cats had a CBC, bio-
chemistry panel, urinalysis, and serum T4 concentration
performed. Of the remaining 10 cats (all <6 years of age),
8 did not have serum T4 concentration measured, 4 had a
hematocrit/plasma protein performed instead of a CBC,
and 2 had semiquantitative assessment of blood urea
nitrogen by dipstick and measurement of urine specific
gravity (USG) instead of a biochemistry panel and com-
plete urinalysis.
The age of the cats ranged from 1.7 to 16.9 years
(mean  SD, 8.6  3.8 years). Body weight ranged from
4.5 to 7.7 kg (mean  SD, 5.5  0.8 kg). Castrated male
cats (18 of 27; 67%) represented the largest sex grouping;
the remaining 9 cats were spayed females. No significant
differences in age (P = .35), body weight (P = .43), or sex
distribution (P = .17) were identified between the treat-
ment groups. Domestic shorthaired cats represented the
most common breed (n = 19/27; 70%), with domestic
longhaired cats (n = 4/27; 15%), Maine Coon (n = 2/27;
7%), Himalayan (n = 1/27; 4%), and Burmese (n = 1/27;
4%) breeds also represented. The dosage of omeprazole
administered to the cats assigned to the omeprazole
group ranged from 1.45 to 2.20 mg/kg (mean  SD,
1.85  0.23 mg/kg). No diarrhea was noted by owners
of any cat in the omeprazole group after administration
Fig 2. Waveform depicting a strongly acidic reflux event (pH < 4.0 designated by black stars) in an 8.3-year-old male-neutered domestic
longhaired cat in the placebo group. The numbered Z channels on the y-axis represent impedance channels spaced throughout the esopha-
gus with Z channel 1 being the most proximal in the esophagus and Z channel 6 representing the most distal impedance channel. Bolus
presence is identified by a drop in impedance by at least 50% of the pre-episode impedance highlighted by the black arrows on Z channels
3–6. Direction of bolus movement in the esophagus is determined by the direction of the impedance change with reflux moving distal to
proximal and swallow moving proximal to distal. The height of reflux is determined by the position of the most proximal channel showing
a drop in impedance (Z channel # 3). Although channel # 7 is positioned on the tracing below the impedance channels, the position of the
pH sensor in the esophagus is at the same level as the most distal impedance channel.
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of the drug. The dentistry procedure time ranged from
1.4 to 5.1 hours (mean  SD, 2.8  0.9 hours), and no
significant difference in procedure time was identified
between treatment groups (P = .65). All cats underwent
periodontal treatment under anesthesia, and 17 of 27 cats
(63%) also required dental extractions. There was no dif-
ference in the procedures performed between groups
(P = .88). No morbidity or death was associated with
anesthesia or the study procedures. No visual evidence of
reflux or regurgitation was recorded in any of the
enrolled cats during the dentistry procedure.
Gastrin
Serum gastrin concentrations were measured in all 27
cats enrolled in the study. Gastrin concentrations in the
placebo group (34.3  10.8 ng/L; range, 22–64 ng/L)
and omeprazole group (45.7 mean  37.2 ng/L; range,
16–135 ng/L) were not significantly different (P = .62).
Gastric pH
Gastric pH was recorded in all 27 cats, but pH readings
were invalid for 1 cat in the placebo group and for 3 cats
in the omeprazole group because of drying of the pH sen-
sor. The drying of the pH sensor did not affect the func-
tioning of the impedance channels that allowed the
continued determination of RE throughout the procedure
in these cats. Gastric pH readings were valid in 23 of 27
cats, representing 13 cats in the placebo group and 10 in
the omeprazole group. Mean gastric pH in the cats that
received omeprazole was 7.2  0.4 (range, 6.6–7.8) and
was significantly higher than the pH in cats that received
the placebo 2.8  1.0 (range, 1.3–4.1; P < .001; Fig 3).
Esophageal pH
Esophageal pH was measured in the same 23 cats as
gastric pH, and results of esophageal pH testing were
not valid in the other 4 cats. Mean esophageal pH for
the omeprazole group was 6.8  0.4 (range, 6.3–7.6)
and was significantly higher (P < .001) than mean pH
for the placebo group 5.3  0.9 (range, 3.8–6.6). An
esophageal pH < 4.0 was documented in 3 of 13 cats in
the placebo group and in none of the cats in the
omeprazole group. In these 3 cats, the mean time of
esophageal pH <4.0 was 106.5  107.2 minutes (range,
7.1–220.0 minutes), or 48.8% of total procedure time.
The mean percentage of total procedural time that the
esophageal pH was <4.0 was 14.2% for the entire pla-
cebo group. Mean percentage of procedural time that
the esophageal pH was <4.0 for the omeprazole group
could not be calculated because a pH <4.0 was not
recorded.
Gastroesophageal Reflux Events
Nine of 27 cats (33.3%) had at least 1 episode of
GER during anesthesia, representing 7 of 14 cats
(50.0%) in the placebo group, and 2 of 13 cats (15.4%)
in the omeprazole group. In total, 14 individual REs
were documented in the 9 cats (Table S1). Of the 9 cats
in which reflux was identified, 6 cats each had a single
reflux event (5 placebo, 1 omeprazole), a single cat had
2 reflux events (placebo), and 2 cats each had 3 separate
reflux events (1 placebo, 1 omeprazole; Table S1).
The height of the refluxate in the esophagus was
determined by impedance data for all 14 REs in the 9
cats that experienced reflux (Table S1). No cat was
noted to have visual evidence of reflux or regurgitation
during or immediately after anesthesia. The mean  SD
number of RE was 0.71  0.94 for the placebo group
(n = 14) and 0.31  0.86 for the omeprazole group
(n = 13). The administration of omeprazole did not sig-
nificantly decrease the number of RE in comparison
with the placebo group (P = .057). The odds ratio of
the placebo group having at least 1 reflux event was
2.75 times the likelihood of a reflux event in the
omeprazole group (95% confidence interval
[CI] = 0.77–9.86; P = .069).
Mean Acid Clearance Time
The mean acid clearance time was calculated for cats
in the placebo group (106.5  107.2 minutes; range,
7.1–220 minutes). Cats in the omeprazole group had no
strongly acidic reflux documented, precluding calcula-
tion of mean acid clearance time.
Discussion
Gastroesophageal reflux (GER) during anesthesia is a
common and well-documented phenomenon in people
and dogs and has been associated with esophagitis,
esophageal stricture formation, and aspiration
pneumonia.1,3 In contrast, GER has been documented
Fig 3. Distribution of gastric and esophageal pH in 23 cats
undergoing elective dental procedures after oral administration of
omeprazole (n = 10 cats) administered twice at 1.45–2.2 mg/kg
18–24 hours before induction and 4 hrs before induction, or pla-
cebo (empty gel cap) (n = 13 cats). The horizontal lines of the box
represent, from bottom to top, the 25th, 50th, and 75th percentiles
of pH values. Whiskers represent the maximum and minimum pH
values, except for outlying observations (solid circles). The symbol
“*” denotes the mean esophageal and gastric pH in the cats that
received omeprazole was significantly higher than the pH in cats
that received the placebo (P < .001)
738 Garcia et al
to occur less frequently in endotracheal-intubated
cats,1–5,13 and the refluxate reached the pharynx in <7%
of cats compared to nearly 25% of dogs.9,10,27 Several
pre-anesthetic and anesthetic agents decrease LES tone
and possibly increase the risk of GER in cats.11,12 These
include commonly used drugs such as atropine, acepro-
mazine, propofol, ketamine, and xylazine. Atropine and
acepromazine administration to cats was shown to
decrease LES pressure to 13.2% of baseline,11 and keta-
mine administration was shown to decrease LES pres-
sure considerably less compared to administration of
propofol, thiopentone, and a combination of xylazine,
ketamine, and atropine in 40 cats undergoing elective
castration or ovariohysterectomy procedures.12
Although not investigated in cats, inhalant anesthetics
also have been shown to decrease LES tone in other
species.27,28
Transient lower esophageal sphincter relaxations
(TLESRs) have been found to be the main mechanism
for all types of RE in humans and provide an alternate
mechanism for GER in cats.29,30 These TLESRs are
vasovagal reflex-mediated, prolonged relaxations of the
LES that occur independent of swallowing. They occur
as a normal physiologic response to gastric distention,
but not gastric pH, and allow venting of gastric gas in
humans, dogs, and cats.29–32 These TLESRs have been
documented to occur in cats under the effects of disso-
ciative anesthetics, making them possibly complicit in
RE under anesthesia.30,31
We found a relatively high incidence of GER in 33%
of the anesthetized cats overall and in 50% of cats that
received placebo. These findings are much higher than
the 12–23% reported previously in intubated anesthetized
cats and likely reflect the use of combined impedance/pH
technology that allowed for detection of weak or nonacid
reflux events as well as strongly acidic reflux events.9,10
Six of 9 reflux events were weak acid reflux events that
could have been missed using the pH monitoring devices
previously employed in GER studies in cats. Other fac-
tors contributing to these divergent results include differ-
ent patient populations and different anesthetic
protocols.9 Despite the high incidence of reflux events in
this study, no cats were observed to have any episodes of
regurgitation during the anesthetic procedure or upon
recovery, supporting previous studies that showed poor
sensitivity for visual detection of reflux.9,10 Despite the
relatively high incidence of GER detected in our cats,
none had an abdominal surgical procedure linked to a
higher incidence of reflux.33
With the aid of computer analysis, the impedance
waveform allows the type (gas vs. liquid), direction (orad
with gastric reflux, aborad with swallowing), and classifi-
cation of the refluxate as strongly acidic (pH < 4), weakly
acidic (4 ≤ pH < 7), or weakly alkaline (pH ≥ 7).34 Our
study utilized dual MII/pH-metry for the detection of
acid and nonacid GER in cats undergoing general anes-
thesia. Historically, all previously published veterinary
studies assessing GER in dogs and cats utilized pH
probes for detection of reflux, with the exception of 1
study in dogs that utilized dual MII/pH-metry.23 Moni-
toring of pH without concurrent impedance monitoring
technology allows for weakly acidic or weakly alkaline
RE, which are characterized by subtle changes in pH,
potentially to be missed, resulting in an underestimation
of the frequency of reflux.15,16 If traditional pH-metry
without impedance technology had been utilized in our
study, only 3 strongly acidic REs would have been docu-
mented out of a total of 14 reflux events.
The PO administration of omeprazole was associated
with a significant increase in both gastric and esopha-
geal pH, and none of the 10 cats in the omeprazole
group that had continuous gastric and esophageal pH
measurements throughout their procedures had a gastric
or esophageal pH < 4.0 at any measured time point.
This marked effect was noted despite administration of
2 PO doses of the PPI within only 24 hours of anesthe-
sia. In the placebo group, 3 cats had periods of time
during which esophageal pH was <4.0, with 2 cats hav-
ing pH <4.0 for over 90 minutes (92.3 and 220.0 min-
utes, respectively). In vivo studies in several domestic
species, including cats, have shown that acute esophagi-
tis can be induced by bathing the esophagus in a combi-
nation of HCl and pepsin, whereas exposure to HCl
alone for protracted periods (up to 1 hour) does not
result in macroscopic or microscopic changes consistent
with acute esophagitis.35–37 Despite the established risk
of pepsin, other enzymes (e.g, trypsin) and bile salts can
cause esophagitis.18,19,38,39 These compounds often have
maximal proteolytic or solubilizing activities at a pH
that can be found in the esophagus after weakly or non-
acid RE. This further highlights the importance of char-
acterizing all types of RE, not just strongly acidic RE.
Anesthesia increases the risk of esophagitis and stricture
formation in part because clearance of esophageal reflux
does not occur under anesthesia.
Omeprazole was administered at a slightly higher
dosage than has been used in previous studies of
cats,40,41 although the dosage is consistent with studies
in dogs showing the efficacy and safety of a higher
dosage of omeprazole.42 Twice-daily dosing of omepra-
zole in cats recently was shown to cause significant acid
suppression in contrast to once-daily administration of
the drug.40
Administration of omeprazole did not significantly
decrease the number of RE in comparison with the pla-
cebo group (P = .057), consistent with previous impe-
dance/pH-metry studies in humans and dogs that failed
to find a decrease in the incidence of reflux with pre-
anesthetic administration of omeprazole or esomepra-
zole (the active S-enantiomer of omeprazole) compared
to controls.23,25 A single study in dogs found that pre-
anesthetic administration of omeprazole decreased the
incidence of reflux, but that study was hampered by the
use of pH monitoring only to detect reflux events.22
The mechanism responsible for decreased reflux in the
omeprazole group is not definitively known, but
omeprazole and esomeprazole have been shown to
decrease gastric volume in both people and cats and
could have decreased the number of TLERs.24,43
Based on the results of our study showing a rela-
tively high prevalence of reflux events in cats during
anesthesia and a significant effect of omeprazole on
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gastric and esophageal pH, future studies should
determine the clinical impact of GER in anesthetized
cats and whether pre-anesthetic administration of PPIs
is warranted. Modification of gastric and esophageal
pH by omeprazole might decrease the risk of
esophagitis and esophageal stricture formation based
on experimental studies performed in rabbits and
cats.19,35,37
The lack of an increase in serum gastrin concentrations
after 2 PO doses of omeprazole to the cats in our study
was unexpected in light of the findings of increases in
serum gastrin concentrations within 24 hours of PPI
administration in dogs and humans.44,45 Serum gastrin
measurements in healthy controls in a previous study
showed a seemingly wide range of concentrations (17–
94 pg/mL) in cats and dogs, with many dogs having
serum gastrin concentrations within the normal reference
interval 24 hours after PPI administration.45,46 It took 4–
5 days for serum gastrin concentration to peak in dogs,
although gastrin concentrations did increase to a level of
significance 24 hours after initiation of omeprazole
therapy.45 A recent study evaluating the long-term effects
(8 weeks) of twice-daily omeprazole orally administered
to 6 healthy adult cats showed a significant increase in
serum gastrin concentrations at 4 weeks and 8 weeks
after initiation of omeprazole administration compared
to placebo, but serum gastrin concentrations were not
determined within the first 24 hours of omeprazole
administration.47 It is plausible that the relatively brief
period after administration of omeprazole and collection
of serum for gastrin determination provided insufficient
time for removal of negative-feedback inhibition of gas-
trin secretion as has been documented in humans.48 The
gastrin assay we used has been validated for cats and has
been used in other studies and is not suspected to be a
source of error.45 Further studies with larger numbers of
animals given omeprazole for a longer duration are indi-
cated to assess the effects of PPIs on serum gastrin con-
centrations in cats.
Our study had several limitations. The relatively
small study numbers of cats in both groups increased
the probability of a type II error. A further limitation
of the study was the loss of pH data from several cats,
including both of the cats that refluxed in the omepra-
zole group. Finally, the lack of a comprehensive moni-
toring system after discharge for the cats that refluxed
precluded our ability to critically evaluate the impact of
these reflux events in the affected cats. Future studies
should include postprocedural monitoring for episodes
of difficulty swallowing, salivation, regurgitation,
odynophagia, and coughing.
In summary, we showed that gastric pH and esopha-
geal pH were significantly increased within 24 hours in
cats that were given 2 PO doses of omeprazole 18–24
and 4 hours before anesthesia, respectively, compared
to cats that received a placebo, but a commensurate
increase in serum gastrin concentrations was not
observed. A relatively high incidence of GER was
detected in 33% of the study cats under anesthesia, with
50% of the cats in the placebo group exhibiting ≥1
reflux event. The odds ratio of the placebo group
having at least 1 reflux event was 2.75 times the likeli-
hood of a reflux event in the omeprazole group (95%
CI = 0.77–9.86; P = .069). Additional studies examining
the effects of orally administered omeprazole on the
incidence and clinical consequences of reflux in a larger
cohort of cats are warranted.
Footnotes
a Azostix Reagent Strips, Siemens Healthcare Diagnostics Inc.,
Tarrytown, NY
b Reichert Vet 360 Refractometer, Reichert Analytical Instru-
ments Inc., Depew, NY
c Microsoft Excel for Mac 2011, Version 14.4.8
d Omeprazole delayed-release capsules USP, Apotex Inc., Toronto,
ON, Canada
e Gastrin [125I] Radioimmunoassay Kit, MP Biomedicals, Diag-
nostics Division, Orangeburg, NY
f Oxymorphone hydrochloride injection (1 mg/mL), Endo Pharma-
ceuticals Inc., Malvern, PA
g Atropine, Baxter Healthcare Corporation, Deerfield, IL
h Propofol, Diprivan, Abbott Laboratories, North Chicago, IL
i Midazolam injection USP, West-Ward Pharmaceuticals, Eaton-
town, NJ
j Isoflurane USP, Piramal Critical Care, Inc., Bethlehem, PA
k Lactated Ringer’s Solution, Baxter Healthcare Corporation,
Deerfield, IL
l Esophageal impedance/pH catheters, model #ZPN-BS-46E, Sand-
hill Scientific, Inc., Highlands Ranch, CO
m PDI lubricating jelly II, Orangeburg, NY
n Vet Oval Loop “Grabber” snare, 2.5 cm loop, Endoscopy Sup-
port Services Inc., Brewster, NY
o Olympus GIF-P140 gastroscope, Olympus America Inc., Center
Valley, PA
p Vet One surgical skin staples, MWI, Boise, ID
q ZepHr Impedance/pH reflux recorder, Sandhill Scientific, Inc.,
Highlands Ranch, CO
r Sandhill Patient Import/Export Utility software version 5.3.0,
Sandhill Scientific, Inc., Highlands Ranch, CO
s Sandhill BioVIEW Analysis software version 5.5.4.1 and Sandhill
pH Analysis software version 4.0.1, Sandhill Scientific, Inc.,
Highlands Ranch, CO
t IBM SPSS version 22.0 software for the Macintosh, IBM Corpo-
ration, Armonk, NY
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Supporting Information
Additional Supporting Information may be found
online in the supporting information tab for this article:
Table S1. Table illustrating the mean esophageal and
gastric pH, and the frequency, type, and height of the reflux
events in 9 of 27 apparently healthy cats that had ≥ 1 reflux
event during anesthesia for an elective dental procedure.
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